Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
19 July 2010
IN THIS ISSUE
Merck job cuts
J&J recall
Counterfeit drugs treaty
Philippines’ drug quality
 
Merck axes 15% of workforce
Merck & Co. has released details of a restructuring plan that calls for the phasing out of operations at eight research sites and eight manufacturing sites, resulting in a 15% reduction of its global workforce. More...
 
J&J expands product recall again
McNeil Consumer Healthcare, a division of Johnson & Johnson, has once again expanded the recall of certain OTC products because of a musty or moldy odor, which has been linked to trace amounts of the chemical 2,4,6 triburomoanisole (TBA). More...
 
New treaty to curb counterfeit drugs
The Council of Europe (CoE) is hoping its ‘Medicrime’ treaty can help curb the lucrative global trade in fake medicines. More...
 
USP works with Philippines to strengthen drug quality
The Laboratory Services Division of the Philippine Food and Drug Administration has attained internationally recognized accreditation for its testing and calibration laboratories, according to an announcement from the US Pharmacopeia (USP). More...
 
State laws affect generic substitution rates and Medicaid costs
States in the US can reduce their Medicaid programs’ healthcare expenditures by changing laws to enable generic drugs to be substituted for branded medications more easily and quickly, according to a new study conducted by CVS Caremark, a large pharmacy healthcare provider. More...
 
PhRMA announces new head
The Pharmaceutical Research and Manufacturers of America (PhRMA) has announced that John J. Castellani will replace Billy Tauzin as President and Chief Executive Officer. More...
 
Join our community on LinkedIn
Want to discuss any of this week’s news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...

Latest blog posts
A pyrrhic victory for sales reps?
Part 11 inspectional activities coming soon
Social media: going where many have gone before
More blog posts

Latest articles
Authenticating drugs with edible microtags
How Raman spectroscopy is benefitting developing and developed countries
Capturing the advantages of co-crystals
More latest articles

Upcoming events
Pharmaceutical Tablet Technology (9–11 August | USA)
CPhI South America (17–19 August | South America)
Extractables & Leachables for Pharmaceutical Products 2010 (14–15 September | UK)
More events

Event Profile
Extractables & Leachables for Pharmaceutical Products 2010
14-15 September 2010
Holiday Inn London Kings Cross Bloomsbury, London


Impurities originating from any part of the manufacturing or storage of drug products can potentially result in expensive product recalls and damage to a company’s reputation, not to mention the serious threat posed to patient safety.

Read more...

Podcast
Vetter
The North American market is critical to Vetter’s strategic global growth as nearly half of its client base is already located here. In order to maximize on this opportunity, Vetter has decided to create a facility, its first outside of Germany, at the Illinois Science + Technology Park in suburban Chicago.

Expansion of Vetter Development Service (VDS)


Survey
If your company was considering/is developing a biosimilar product, what would be your biggest concern?
Development costs   21%
Safety concerns   21%
Regulatory process   30%
Legal challenges   16%
Increased competition to innovative biologics   0%
The threat to biotech innovation   3%
No concerns; healthcare providers should have the option to prescribe a biosimilar   9%

This week we would like to know...

Has your company initiated a program to make its processes more green?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom